CN100569228C - 用于治疗癌症的脂肪酸类似物 - Google Patents

用于治疗癌症的脂肪酸类似物 Download PDF

Info

Publication number
CN100569228C
CN100569228C CNB018127177A CN01812717A CN100569228C CN 100569228 C CN100569228 C CN 100569228C CN B018127177 A CNB018127177 A CN B018127177A CN 01812717 A CN01812717 A CN 01812717A CN 100569228 C CN100569228 C CN 100569228C
Authority
CN
China
Prior art keywords
cell
tumor
cancer
alkyl
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018127177A
Other languages
English (en)
Chinese (zh)
Other versions
CN1441671A (zh
Inventor
R·伯奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thia Medica AS
Original Assignee
Thia Medica AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica AS filed Critical Thia Medica AS
Publication of CN1441671A publication Critical patent/CN1441671A/zh
Application granted granted Critical
Publication of CN100569228C publication Critical patent/CN100569228C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNB018127177A 2000-07-13 2001-07-13 用于治疗癌症的脂肪酸类似物 Expired - Fee Related CN100569228C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20003591 2000-07-13
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft

Publications (2)

Publication Number Publication Date
CN1441671A CN1441671A (zh) 2003-09-10
CN100569228C true CN100569228C (zh) 2009-12-16

Family

ID=19911376

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018127177A Expired - Fee Related CN100569228C (zh) 2000-07-13 2001-07-13 用于治疗癌症的脂肪酸类似物

Country Status (17)

Country Link
US (1) US7378443B2 (enExample)
EP (1) EP1313463B1 (enExample)
JP (1) JP2004502732A (enExample)
KR (2) KR20080071598A (enExample)
CN (1) CN100569228C (enExample)
AT (1) ATE320802T1 (enExample)
AU (2) AU7286001A (enExample)
BR (1) BR0112399A (enExample)
CA (1) CA2414480A1 (enExample)
DE (1) DE60118198T2 (enExample)
ES (1) ES2261441T3 (enExample)
MX (1) MXPA02012944A (enExample)
NO (2) NO20003591L (enExample)
NZ (1) NZ523316A (enExample)
RU (1) RU2283105C2 (enExample)
WO (1) WO2002003983A1 (enExample)
ZA (1) ZA200210028B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
RU2331649C2 (ru) 2002-06-20 2008-08-20 Ай-Си Ви-И-Си Лимитед Серосодержащие фосфолипидные производные, содержащая их фармацевтическая композиция, их применение для лечения заболеваний и способ их получения
EP1784223A2 (en) 2004-07-19 2007-05-16 Thia Medica AS Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
NO20053519L (no) * 2005-07-18 2007-01-19 Thia Medica As Anvendelse av forbindelser som omfatter fettsyrer
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
WO2010033878A2 (en) 2008-09-19 2010-03-25 David Brown Solute concentration measurement device and related methods
US20110152770A1 (en) 2009-07-30 2011-06-23 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
EP2983658B1 (en) 2013-03-11 2024-05-01 Sciadonics, Inc. Lipid compositions containing bioactive fatty acids
AU2014229506B2 (en) 2013-03-11 2017-04-13 Nobesita As Natural lipids containing non-oxidizable fatty acids
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
DE102014116958B9 (de) * 2014-11-19 2017-10-05 Trumpf Laser- Und Systemtechnik Gmbh Optisches System zur Strahlformung eines Laserstrahls, Laserbearbeitungsanlage, Verfahren zur Materialbearbeitung und Verwenden einer gemeinsamen langgezogenen Fokuszone zur Lasermaterialbearbeitung
BR112017026709A2 (pt) * 2015-06-11 2018-08-28 Univ Miami tratamento e diagnóstico de câncer
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用
CN107235880B (zh) * 2017-06-30 2018-10-30 江南大学 一种含硒阳离子表面活性剂及其应用
GB201910644D0 (en) * 2019-07-25 2019-09-11 Coegin Pharma As Cancer Treatment
ES3041492T3 (en) 2019-12-18 2025-11-12 Stinginn Llc Substituted 1,2, 4-triazoles and methods of use
US11897888B1 (en) 2020-04-30 2024-02-13 Stinginn Llc Small molecular inhibitors of sting signaling compositions and methods of use
CN115260964A (zh) * 2022-08-29 2022-11-01 烟台市福山义昌精细化工厂 一种石油油管丝扣专用密封胶及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046237A (en) * 1995-07-14 2000-04-04 Berge; Rolf Non-β-oxidizable fatty acid analogues, their uses as therapeutic active medicaments

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686377B2 (ja) * 1985-09-30 1994-11-02 日清製粉株式会社 がん転移抑制剤
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
JPH0797320A (ja) * 1993-08-04 1995-04-11 Takuma Sasaki 制癌剤
US6358915B1 (en) * 1995-03-07 2002-03-19 George Washington University Methods for inhibiting metastasis
US5750515A (en) * 1995-04-10 1998-05-12 Taiho Pharmaceutical Co., Ltd. Cancer metastasis inhibitor
DE69726182T2 (de) * 1996-12-11 2004-08-12 Dana-Farber Cancer Institute, Inc., Boston Methoden und pharmazeutische zusammenstellungen zur wachstumsverhinderung von tumorzellen enthaltend einen ppar-gamma agonisten und einen map kinase inhibitor
DE19700774A1 (de) * 1997-01-13 1998-07-16 Hoechst Ag Antiadhäsive Sulfatid-Mimetika
AU7240398A (en) * 1998-05-08 1999-11-29 Rolf Berge Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions
JP4993878B2 (ja) * 2005-06-28 2012-08-08 ダイキョーニシカワ株式会社 多気筒エンジンの吸気装置

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046237A (en) * 1995-07-14 2000-04-04 Berge; Rolf Non-β-oxidizable fatty acid analogues, their uses as therapeutic active medicaments

Also Published As

Publication number Publication date
KR20080071598A (ko) 2008-08-04
NO20025930L (no) 2003-01-13
CN1441671A (zh) 2003-09-10
ES2261441T3 (es) 2006-11-16
MXPA02012944A (es) 2004-05-17
NZ523316A (en) 2004-09-24
KR100861428B1 (ko) 2008-10-02
WO2002003983A1 (en) 2002-01-17
NO20003591D0 (no) 2000-07-13
NO20025930D0 (no) 2002-12-11
KR20030016399A (ko) 2003-02-26
US20040024063A1 (en) 2004-02-05
ATE320802T1 (de) 2006-04-15
NO20003591L (no) 2002-01-14
CA2414480A1 (en) 2002-01-17
DE60118198T2 (de) 2007-01-25
ZA200210028B (en) 2004-01-26
AU7286001A (en) 2002-01-21
NO324634B1 (no) 2007-11-26
JP2004502732A (ja) 2004-01-29
EP1313463A1 (en) 2003-05-28
EP1313463B1 (en) 2006-03-22
US7378443B2 (en) 2008-05-27
RU2283105C2 (ru) 2006-09-10
HK1057473A1 (zh) 2004-04-08
DE60118198D1 (de) 2006-05-11
AU2001272860B2 (en) 2005-11-24
BR0112399A (pt) 2003-05-27

Similar Documents

Publication Publication Date Title
CN100569228C (zh) 用于治疗癌症的脂肪酸类似物
JP2020524706A (ja) 結節性硬化症複合体の処置におけるカンナビジオールの使用
AU2001272860A1 (en) Fatty acid analogues for the treatment of cancer
CN101940569B (zh) 含有索拉非尼和青蒿素及青蒿素类衍生物的药物组合物及其在制备治疗癌症的药物中的应用
US7008961B1 (en) Composition and method for treating carcinoma
CN109793727A (zh) 一种有效抗恶性肿瘤的药物组合物及其应用
CN112089710B (zh) 4-羟基异亮氨酸在制备抗肿瘤药物中的应用
CN110664807B (zh) 一种具有协同抗黑色素瘤功效的药物组合物及其应用
US20030012825A1 (en) Metallized molecule therapies
CN116687890A (zh) 紫檀芪在制备治疗乳腺癌骨转移的药物中的应用
CN111249274B (zh) 银杏内酯b在制备胶质瘤细胞活性抑制剂中的应用
CN109481424A (zh) 异甘草素、药物组合物及其在治疗糖尿病肾病中的应用
HK1057473B (en) Fatty acid analogues for the treatment of cancer
CN102440987A (zh) 含有芹菜素及芹菜素类衍生物和青蒿素及青蒿素类衍生物的药物组合物及其应用
US20240058292A1 (en) Pharmaceutical composition for treating cancer, and preparation method and use thereof
CN109498547A (zh) 一种平阳霉素局部注射制剂及其制备方法
US20040048807A1 (en) Angiogenesis inhibitors
Zhu et al. Establishment of nude mice model of human osteosarcoma cell MG63 with different potential of metastasis
CN103933039B (zh) 一种含水飞蓟宾和索拉非尼的药物组合物及其应用
CN115317482A (zh) 氯喹及其衍生物在制备改善鼻咽癌预后药物中的应用
CN100560075C (zh) 调节脂类代谢的药物
CN101766589A (zh) 化合物2-甲基戊酸离子聚合体用于制备抗肿瘤药物的应用
TW202023576A (zh) 含有亞鐵胺基酸粒子的組合物及其用於製造治療或改善胰臟相關疾病的醫藥品的用途
KR20020026743A (ko) 비소화합물 및 글루타치온 고갈 유도 화합물을 함유하는항암조성물
LAYTON to be congratulated on producing volume

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1057473

Country of ref document: HK

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20091216

Termination date: 20100713